Inaktiver Wert

Andere Sprachen Tiger X Medical Inc Other OTC

Aktien

US88677A1043

Schlusskurs Other OTC Andere Börsenplätze
- ^USD	-

07.06.	BioCardia erhält Patent für transendokardialen Katheter zur biotherapeutischen Verabreichung; Aktien steigen vorbörslich	MT
21.05.	BioCardia will Aktiensplit im Verhältnis 1:15 durchführen; Aktien fallen nachbörslich	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioCardia Receives Patent for Transendocardial Biotherapeutic Delivery Catheter; Shares Rise Pre-Bell	07.06.
BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach	07.06.
BioCardia to Implement 1-for-15 Reverse Stock Split; Shares Fall After Hours	21.05.
BioCardia Announces Reverse Stock Split	21.05.
BioCardia, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results	14.05.
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024	09.05.
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes	01.05.
BioCardia, Inc. Announces the Primary Endpoint Results of the Open Label Roll-In Cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial	01.05.
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort	25.04.
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort	25.04.
BioCardia, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
BioCardia : Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results	27.03.
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024	20.03.
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership	13.03.
BioCardia, Inc. and StemCardia, Inc. Announce Long-Term Partnership to Advance StemCardia?s Investigational Pluripotent Stem Cell Product Candidate for Treatment of Heart Failure	13.03.
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study	12.03.
BioCardiaAnnounces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study	12.03.
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure	04.03.
Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure	04.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Tiger X Medical Inc Other OTC

Aktien

US88677A1043

Andere Sprachen

Filter